Posts in: heltzen (2)

MDB Capital: eXoZymes & NCTx: The Breakthrough Opportunity with NCTx and Treating a Global Health Epidemic
heltzeninvestorpress clippingsvideo
MDB Capital: eXoZymes & NCTx: The Breakthrough Opportunity with NCTx and Treating a Global Health EpidemicSeptember 18, 2025
Michael Heltzen & Erum Azeez Khan
heltzenpress releaseinvestorpress clippings
Podcast: eXoZymes highlights scalable biomanufacturing platform and first spinout, NCTx, on 'Grow Everything'May 16, 2025
Slack Capital: EXOZ investment report and CEO interview
heltzeninvestorpress clippingsvideo
Slack Capital: EXOZ investment report and CEO interviewMay 13, 2025
ARCHIVE: Fox Business: Interview with CEO Michael Heltzen
heltzeninvestorpress clippingsvideoARCHIVE
ARCHIVE: Fox Business: Interview with CEO Michael HeltzenMarch 3, 2025
ARCHIVE: Watch eXoZymes' Nasdaq closing bell ceremony
heltzeninvestorvideoARCHIVE
ARCHIVE: Watch eXoZymes' Nasdaq closing bell ceremonyFebruary 20, 2025
ARCHIVE: Looking at the rest of 2025 - part 4 of a fireside chat about Invizyne
heltzeninvestorvideoARCHIVE
ARCHIVE: Looking at the rest of 2025 - part 4 of a fireside chat about InvizyneFebruary 11, 2025
ARCHIVE: Go To Market Strategy - part 3 of a fireside chat about Invizyne
heltzeninvestorvideoARCHIVE
ARCHIVE: Go To Market Strategy - part 3 of a fireside chat about InvizyneJanuary 15, 2025
ARCHIVE: Using AI for Enzyme Engineering - Part 2 of a Fireside Chat About Invizyne
heltzeninvestorvideoARCHIVE
ARCHIVE: Using AI for Enzyme Engineering - Part 2 of a Fireside Chat About InvizyneJanuary 7, 2025
ARCHIVE: Looking back at 2024 - part 1 of a fireside chat about Invizyne
heltzeninvestorvideoARCHIVE
ARCHIVE: Looking back at 2024 - part 1 of a fireside chat about InvizyneDecember 31, 2024
Previous page
Page 2 of 2
Next page